User profiles for Didier Raoult

Didier Raoult

IHU Méditerranée Infection, Aix Marseille Université, AP-HM CHU Timone, Marseille …
Verified email at univ-amu.fr
Cited by 233089

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

…, B La Scola, JM Rolain, P Brouqui, D Raoult - International journal of …, 2020 - Elsevier
Background Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2,
and reported to be efficient in Chinese COV-19 patients. We evaluate the effect of …

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

…, B Escudier, MD Hellmann, A Eggermont, D Raoult… - Science, 2018 - science.org
Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis induce sustained clinical
responses in a sizable minority of cancer patients. We found that primary resistance to ICIs …

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

…, N Chaput, C Robert, C Mateus, G Kroemer, D Raoult… - Science, 2015 - science.org
Antibodies targeting CTLA-4 have been successfully used as cancer immunotherapy. We
find that the antitumor effects of CTLA-4 blockade depend on distinct Bacteroides species. In …

Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry

…, PE Fournier, JM Rolain, D Raoult - Clinical infectious …, 2009 - academic.oup.com
Background . Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass
spectrometry accurately identifies both selected bacteria and bacteria in select clinical …

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

CA Devaux, JM Rolain, P Colson, D Raoult - International journal of …, 2020 - Elsevier
Recently, a novel coronavirus (2019-nCoV), officially known as severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Despite drastic containment …

Ticks and tickborne bacterial diseases in humans: an emerging infectious threat

P Parola, D Raoult - Clinical infectious diseases, 2001 - academic.oup.com
Ticks are currently considered to be second only to mosquitoes as vectors of human infectious
diseases in the world. Each tick species has preferred environmental conditions and …

[HTML][HTML] Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards

…, C Grimaldier, P Colson, P Gautret, D Raoult - European Journal of …, 2020 - Springer
In a preliminary clinical study, we observed that the combination of hydroxychloroquine and
azithromycin was effective against SARS-CoV-2 by shortening the duration of viral load in …

16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates

…, A Carlioz, R Martelin, JP Gayral, D Raoult - Journal of clinical …, 2000 - Am Soc Microbiol
Some bacteria are difficult to identify with phenotypic identification schemes commonly used
outside reference laboratories. 16S ribosomal DNA (rDNA)-based identification of bacteria …

[PDF][PDF] Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

…, JM Rolain, JC Lagier, P Brouqui, D Raoult - International journal of …, 2020 - Elsevier
Repositioning of drugs to use as antiviral treatment is a critical need [1]. It is commonly very
26 badly perceived by virologists, as we experienced this in reporting the effectiveness of 27 …

The abundance and variety of carbohydrate-active enzymes in the human gut microbiota

…, F Armougom, JI Gordon, D Raoult… - Nature Reviews …, 2013 - nature.com
Descriptions of the microbial communities that live on and in the human body have
progressed at a spectacular rate over the past 5 years, fuelled primarily by highly parallel DNA-…